← SearchCOVID-19 DEVELOPMENT OF LUNGPACER-PPROTECT, A NEUROSTIMULATION DEVICE TO IMPROVE RESPIRATORY HEALTH AND OUTCOMES FOR MECHANICALLY VENTILATED PATIENTS$5,355,538FY2021Defense Health AgencyDODLungpacer Medical Usa IncInvestigatorsView source on USAspending →